TRANEXAMIC ACID

TRANEXAMIC ACID was reported 9077 times

These side effects are most commonly reported by patients taking TRANEXAMIC ACID:

# Side effect Count
0 DRUG INEFFECTIVE 662
1 OFF LABEL USE 657
2 PYREXIA 373
3 NAUSEA 351
4 HYPOTENSION 340
5 DIARRHOEA 319
6 HAEMORRHAGE 317
7 VOMITING 310
8 DYSPNOEA 299
9 PNEUMONIA 282
10 FEBRILE NEUTROPENIA 267
11 HEADACHE 244
12 ANAEMIA 240
13 ANAPHYLACTIC REACTION 235
14 FATIGUE 230
15 PLATELET COUNT DECREASED 222
16 SEIZURE 219
17 PAIN 200
18 PULMONARY EMBOLISM 199
19 DIZZINESS 193
20 RASH 186
21 TACHYCARDIA 186
22 THROMBOCYTOPENIA 184
23 MALAISE 180
24 DRUG INTERACTION 175
25 ACUTE KIDNEY INJURY 171
26 EPISTAXIS 171
27 ARTHRALGIA 170
28 ABDOMINAL PAIN 169
29 HAEMOGLOBIN DECREASED 168
30 URTICARIA 164
31 DEATH 161
32 SEPSIS 159
33 HYPERTENSION 149
34 CARDIAC ARREST 148
35 PRODUCT USE IN UNAPPROVED INDICATION 139
36 MYOCLONUS 133
37 BACK PAIN 129
38 GASTROINTESTINAL HAEMORRHAGE 128
39 CONDITION AGGRAVATED 125
40 FALL 124
41 HEREDITARY ANGIOEDEMA 124
42 MATERNAL EXPOSURE DURING PREGNANCY 123
43 WEIGHT DECREASED 123
44 COUGH 122
45 ANGIOEDEMA 119
46 PRURITUS 117
47 CHEST PAIN 116
48 GENERALISED TONIC-CLONIC SEIZURE 113
49 HYPERSENSITIVITY 112
50 MUCOSAL INFLAMMATION 110
51 ASTHENIA 108
52 DEEP VEIN THROMBOSIS 107
53 INSOMNIA 106
54 MUSCLE SPASMS 106
55 ANXIETY 105
56 APLASTIC ANAEMIA 105
57 BLOOD PRESSURE INCREASED 105
58 ANAPHYLACTIC SHOCK 103
59 DECREASED APPETITE 103
60 DISEASE PROGRESSION 101
61 CHILLS 100
62 NEUTROPENIA 99
63 ALANINE AMINOTRANSFERASE INCREASED 98
64 CONTUSION 98
65 HAEMOPTYSIS 96
66 PLEURAL EFFUSION 96
67 THROMBOSIS 96
68 VAGINAL HAEMORRHAGE 96
69 OEDEMA PERIPHERAL 95
70 PAIN IN EXTREMITY 95
71 STATUS EPILEPTICUS 95
72 SYNCOPE 94
73 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 90
74 ERYTHEMA 90
75 PRODUCT USE ISSUE 90
76 PANCYTOPENIA 89
77 CONFUSIONAL STATE 88
78 CONSTIPATION 88
79 COVID-19 88
80 SOMNOLENCE 88
81 WRONG PRODUCT ADMINISTERED 88
82 LOSS OF CONSCIOUSNESS 87
83 BLOOD PRESSURE DECREASED 86
84 OXYGEN SATURATION DECREASED 86
85 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 85
86 ACUTE MYOCARDIAL INFARCTION 84
87 RENAL FAILURE 84
88 HYPOXIA 81
89 HYPOKALAEMIA 80
90 WEIGHT INCREASED 79
91 MIGRAINE 76
92 CEREBRAL INFARCTION 75
93 MELAENA 75
94 MYALGIA 75
95 RESPIRATORY FAILURE 75
96 URINARY TRACT INFECTION 75
97 WHITE BLOOD CELL COUNT DECREASED 75
98 EXPOSURE DURING PREGNANCY 74
99 TREMOR 73
100 NASOPHARYNGITIS 72
101 HEART RATE INCREASED 70
102 INFECTION 70
103 RASH ERYTHEMATOUS 69
104 ABDOMINAL PAIN UPPER 68
105 RASH MACULO-PAPULAR 68
106 RECTAL HAEMORRHAGE 68
107 CEREBROVASCULAR ACCIDENT 67
108 HEPATIC FUNCTION ABNORMAL 67
109 RENAL IMPAIRMENT 67
110 SHOCK HAEMORRHAGIC 67
111 INTERSTITIAL LUNG DISEASE 66
112 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66
113 FOETAL EXPOSURE DURING PREGNANCY 64
114 GAIT DISTURBANCE 64
115 ATRIAL FIBRILLATION 63
116 INTENTIONAL PRODUCT USE ISSUE 63
117 ABDOMINAL DISCOMFORT 62
118 COAGULOPATHY 62
119 GENERAL PHYSICAL HEALTH DETERIORATION 62
120 HYPOAESTHESIA 62
121 THERAPY NON-RESPONDER 62
122 MYOCARDIAL INFARCTION 61
123 PERIPHERAL SWELLING 61
124 TOXICITY TO VARIOUS AGENTS 61
125 ASPARTATE AMINOTRANSFERASE INCREASED 60
126 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60
127 INFLUENZA 60
128 ABDOMINAL DISTENSION 59
129 BRADYCARDIA 59
130 PALPITATIONS 59
131 C-REACTIVE PROTEIN INCREASED 58
132 PARAESTHESIA 58
133 SEPTIC SHOCK 58
134 CEREBRAL HAEMORRHAGE 57
135 HAEMATOMA 57
136 MALIGNANT NEOPLASM PROGRESSION 57
137 CHEST DISCOMFORT 56
138 DEHYDRATION 56
139 FEELING ABNORMAL 56
140 HEAVY MENSTRUAL BLEEDING 56
141 OVERDOSE 55
142 SWELLING 55
143 BLOOD BILIRUBIN INCREASED 53
144 SWELLING FACE 53
145 DELIRIUM 52
146 NO ADVERSE EVENT 52
147 PREMATURE BABY 52
148 DEPRESSED LEVEL OF CONSCIOUSNESS 51
149 HAEMOTHORAX 51
150 HYPONATRAEMIA 51
151 CIRCULATORY COLLAPSE 50
152 MUSCULAR WEAKNESS 50
153 NEUROTOXICITY 50
154 NEUTROPHIL COUNT DECREASED 50
155 PLATELET COUNT INCREASED 50
156 SHOCK 50
157 VISUAL IMPAIRMENT 50
158 WHEEZING 49
159 AGITATION 48
160 BRONCHITIS 48
161 DEPRESSION 47
162 RENAL FAILURE ACUTE 47
163 SWOLLEN TONGUE 47
164 CARDIAC FAILURE 46
165 HYPERHIDROSIS 46
166 NEUROPATHY PERIPHERAL 46
167 PNEUMOTHORAX 46
168 PRODUCT DOSE OMISSION ISSUE 46
169 VISION BLURRED 46
170 DRUG HYPERSENSITIVITY 45
171 DYSPHAGIA 45
172 FACE OEDEMA 45
173 HAEMATEMESIS 45
174 HAEMATOCHEZIA 45
175 OROPHARYNGEAL PAIN 45
176 POST PROCEDURAL HAEMORRHAGE 45
177 PULMONARY OEDEMA 45
178 TRANSFUSION 45
179 TREATMENT FAILURE 44
180 WHITE BLOOD CELL COUNT INCREASED 44
181 APHASIA 43
182 DISSEMINATED INTRAVASCULAR COAGULATION 43
183 HAEMARTHROSIS 43
184 IMMUNE THROMBOCYTOPENIA 43
185 POOR VENOUS ACCESS 43
186 BLOOD CREATININE INCREASED 42
187 NEUTROPENIC SEPSIS 42
188 PULMONARY HAEMORRHAGE 42
189 DYSPEPSIA 41
190 FLUSHING 41
191 ILLNESS 41
192 PURPURA 41
193 ACUTE MYELOID LEUKAEMIA 40
194 CARDIO-RESPIRATORY ARREST 40
195 CONVULSION 40
196 EPILEPSY 40
197 HAEMATURIA 40
198 ISCHAEMIC STROKE 40
199 LEUKOPENIA 40
200 SUICIDAL IDEATION 40
201 UPPER GASTROINTESTINAL HAEMORRHAGE 40
202 MEDICATION ERROR 39
203 SINUSITIS 39
204 BLISTER 38
205 BRAIN OEDEMA 38
206 DISORIENTATION 38
207 GINGIVAL BLEEDING 38
208 INCORRECT DOSE ADMINISTERED 38
209 STRESS 38
210 HAEMODYNAMIC INSTABILITY 37
211 OEDEMA 37
212 VENTRICULAR FIBRILLATION 37
213 DEVICE RELATED INFECTION 36
214 INTENTIONAL OVERDOSE 36
215 JOINT SWELLING 36
216 METABOLIC ACIDOSIS 36
217 NECK PAIN 36
218 RESPIRATORY DISTRESS 36
219 SINUS TACHYCARDIA 36
220 STEVENS-JOHNSON SYNDROME 36
221 BLOOD ALKALINE PHOSPHATASE INCREASED 35
222 HAEMORRHAGE INTRACRANIAL 35
223 INFUSION RELATED REACTION 35
224 INJECTION SITE PAIN 35
225 NASAL CONGESTION 35
226 ACUTE RESPIRATORY DISTRESS SYNDROME 34
227 ARRHYTHMIA 34
228 CHOLESTASIS 34
229 CYANOSIS 34
230 DYSPHONIA 34
231 EYE PAIN 34
232 GASTRITIS 34
233 HYPOGLYCAEMIA 34
234 HYPOVOLAEMIA 34
235 PNEUMONIA ASPIRATION 34
236 BACTERAEMIA 33
237 BRONCHOSPASM 33
238 FEELING HOT 33
239 HERPES ZOSTER 33
240 VENTRICULAR TACHYCARDIA 33
241 ALOPECIA 32
242 CARDIOGENIC SHOCK 32
243 GASTROINTESTINAL DISORDER 32
244 HYPERKALAEMIA 32
245 LIVER DISORDER 32
246 PREMATURE DELIVERY 32
247 STRIDOR 32
248 VASODILATATION 32
249 HEPATIC FAILURE 31
250 MYELODYSPLASTIC SYNDROME 31
251 PALLOR 31
252 ASCITES 30
253 EMPHYSEMA 30
254 FUNGAL INFECTION 30
255 MATERNAL EXPOSURE DURING DELIVERY 30
256 PLATELET COUNT ABNORMAL 30
257 URINARY RETENTION 30
258 BLOOD CREATINE PHOSPHOKINASE INCREASED 29
259 BLOOD LACTATE DEHYDROGENASE INCREASED 29
260 FLATULENCE 29
261 LYMPHOCYTE COUNT DECREASED 29
262 TRANSAMINASES INCREASED 29
263 VENOOCCLUSIVE LIVER DISEASE 29
264 ANGIOPATHY 28
265 DIABETES MELLITUS 28
266 HEPATIC CYTOLYSIS 28
267 LIP SWELLING 28
268 RHABDOMYOLYSIS 28
269 THERAPEUTIC RESPONSE DECREASED 28
270 ACUTE RESPIRATORY FAILURE 27
271 ADVERSE REACTION 27
272 ASTHMA 27
273 BLOOD UREA INCREASED 27
274 COLITIS 27
275 DRUG ERUPTION 27
276 DRUG-INDUCED LIVER INJURY 27
277 MYOCLONIC EPILEPSY 27
278 UTERINE HAEMORRHAGE 27
279 BONE PAIN 26
280 GRAND MAL CONVULSION 26
281 INSPIRATORY CAPACITY DECREASED 26
282 MEMORY IMPAIRMENT 26
283 STOMATITIS 26
284 TOXIC EPIDERMAL NECROLYSIS 26
285 UTERINE LEIOMYOMA 26
286 DRUG INTOLERANCE 25
287 HAEMOGLOBIN INCREASED 25
288 HEPATIC ENZYME INCREASED 25
289 JAUNDICE 25
290 MECHANICAL VENTILATION COMPLICATION 25
291 MOUTH HAEMORRHAGE 25
292 PHARYNGEAL SWELLING 25
293 PRODUCT PACKAGING CONFUSION 25
294 PRURITUS GENERALISED 25
295 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25
296 BLOOD GLUCOSE INCREASED 24
297 CORONARY ARTERY THROMBOSIS 24
298 DISTURBANCE IN ATTENTION 24
299 FOOD ALLERGY 24
300 HALLUCINATION 24
301 HOT FLUSH 24
302 LETHARGY 24
303 LUNG DISORDER 24
304 MENORRHAGIA 24
305 MENTAL DISORDER 24
306 RESTLESSNESS 24
307 DISCOMFORT 23
308 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23
309 ENCEPHALOPATHY 23
310 HEMIPARESIS 23
311 HYPERGLYCAEMIA 23
312 JOINT STIFFNESS 23
313 MULTI-ORGAN FAILURE 23
314 PLASMA CELL MYELOMA 23
315 PNEUMONITIS 23
316 PULMONARY ALVEOLAR HAEMORRHAGE 23
317 RED BLOOD CELL COUNT DECREASED 23
318 THROMBOTIC MICROANGIOPATHY 23
319 TREATMENT NONCOMPLIANCE 23
320 UNRESPONSIVE TO STIMULI 23
321 UTERINE DISORDER 23
322 AMENORRHOEA 22
323 BACTERIAL INFECTION 22
324 GASTROOESOPHAGEAL REFLUX DISEASE 22
325 HAEMATOCRIT DECREASED 22
326 HEAD INJURY 22
327 HYPOCALCAEMIA 22
328 LIMB INJURY 22
329 LIVER FUNCTION TEST ABNORMAL 22
330 MUSCLE HAEMORRHAGE 22
331 NEUTROPHIL COUNT INCREASED 22
332 OBSTRUCTIVE AIRWAYS DISORDER 22
333 PRODUCT PRESCRIBING ISSUE 22
334 TACHYPNOEA 22
335 AGGRESSION 21
336 BLINDNESS 21
337 BLOOD URINE PRESENT 21
338 CEREBRAL VENOUS SINUS THROMBOSIS 21
339 CHRONIC KIDNEY DISEASE 21
340 DERMATITIS CONTACT 21
341 ENTEROCOCCAL SEPSIS 21
342 HYPOPHOSPHATAEMIA 21
343 ISCHAEMIA 21
344 LYMPHADENOPATHY 21
345 MUSCULOSKELETAL STIFFNESS 21
346 PNEUMOCYSTIS JIROVECII PNEUMONIA 21
347 PULSELESS ELECTRICAL ACTIVITY 21
348 RESPIRATORY DISORDER 21
349 RETINAL ARTERY OCCLUSION 21
350 RHEUMATOID ARTHRITIS 21
351 SUICIDE ATTEMPT 21
352 WOUND 21
353 ACCIDENTAL EXPOSURE TO PRODUCT 20
354 ALTERED STATE OF CONSCIOUSNESS 20
355 BODY TEMPERATURE INCREASED 20
356 BRONCHOPULMONARY ASPERGILLOSIS 20
357 CONCUSSION 20
358 DYSKINESIA 20
359 HEART RATE DECREASED 20
360 HYPOPHAGIA 20
361 ILEUS 20
362 INFLUENZA LIKE ILLNESS 20
363 IRRITABILITY 20
364 KIDNEY INFECTION 20
365 OVARIAN CYST 20
366 PLATELET TRANSFUSION 20
367 POST PROCEDURAL COMPLICATION 20
368 RHINORRHOEA 20
369 STAPHYLOCOCCAL INFECTION 20
370 TINNITUS 20
371 VASCULAR STENT THROMBOSIS 20
372 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19
373 ADRENAL INSUFFICIENCY 19
374 BALANCE DISORDER 19
375 BURNING SENSATION 19
376 CARDIAC FAILURE CONGESTIVE 19
377 COGNITIVE DISORDER 19
378 HIATUS HERNIA 19
379 HYPERAESTHESIA 19
380 INFUSION SITE PAIN 19
381 LARYNGEAL OEDEMA 19
382 LOW BIRTH WEIGHT BABY 19
383 MOBILITY DECREASED 19
384 MUSCLE RIGIDITY 19
385 PANCREATITIS 19
386 PERIORBITAL OEDEMA 19
387 PRODUCTIVE COUGH 19
388 SPEECH DISORDER 19
389 STRESS CARDIOMYOPATHY 19
390 SUPRAVENTRICULAR TACHYCARDIA 19
391 THERAPEUTIC PRODUCT EFFECT DECREASED 19
392 TOOTHACHE 19
393 BLOOD ALBUMIN DECREASED 18
394 BLOOD DISORDER 18
395 BLOOD IRON DECREASED 18
396 BONE MARROW FAILURE 18
397 CAESAREAN SECTION 18
398 CARDIOVASCULAR DISORDER 18
399 CELLULITIS 18
400 COLITIS ISCHAEMIC 18
401 CYSTITIS HAEMORRHAGIC 18
402 DISEASE RECURRENCE 18
403 DIVERTICULITIS 18
404 EMBOLISM VENOUS 18
405 FACTOR VIII INHIBITION 18
406 GASTROENTERITIS VIRAL 18
407 INFLAMMATION 18
408 LACTIC ACIDOSIS 18
409 LEUKOCYTOSIS 18
410 LOWER RESPIRATORY TRACT INFECTION 18
411 MUSCULOSKELETAL PAIN 18
412 MYDRIASIS 18
413 OESOPHAGITIS 18
414 POLYURIA 18
415 PRESYNCOPE 18
416 RASH PRURITIC 18
417 RESPIRATORY ARREST 18
418 RESPIRATORY TRACT INFECTION 18
419 UPPER RESPIRATORY TRACT INFECTION 18
420 ARTHRITIS 17
421 BLOOD PRESSURE FLUCTUATION 17
422 BREAST CANCER 17
423 CROHN^S DISEASE 17
424 DEPRESSED MOOD 17
425 EMOTIONAL DISTRESS 17
426 ENTEROCOLITIS 17
427 EOSINOPHILIA 17
428 GASTROENTERITIS 17
429 GENERALISED OEDEMA 17
430 HYPERTHERMIA 17
431 LIVE BIRTH 17
432 MYOPATHY 17
433 OSTEOARTHRITIS 17
434 PERICARDIAL EFFUSION 17
435 PETECHIAE 17
436 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17
437 PRESCRIBED OVERDOSE 17
438 PROCEDURAL HAEMORRHAGE 17
439 RASH GENERALISED 17
440 RENAL CORTICAL NECROSIS 17
441 SKIN DISCOLOURATION 17
442 STAPHYLOCOCCAL SEPSIS 17
443 SURGERY 17
444 TUMOUR LYSIS SYNDROME 17
445 URINE OUTPUT DECREASED 17
446 AMNESIA 16
447 DRY SKIN 16
448 FEELING COLD 16
449 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16
450 HAEMORRHAGIC DIATHESIS 16
451 HYPOALBUMINAEMIA 16
452 INJURY 16
453 INTENTIONAL SELF-INJURY 16
454 MYELOSUPPRESSION 16
455 NEOPLASM PROGRESSION 16
456 NORMAL NEWBORN 16
457 ORAL CANDIDIASIS 16
458 PERITONITIS 16
459 PHARYNGEAL OEDEMA 16
460 POSTPARTUM HAEMORRHAGE 16
461 PROCEDURAL PAIN 16
462 RED BLOOD CELL TRANSFUSION 16
463 SEROTONIN SYNDROME 16
464 UNDERDOSE 16
465 VASCULITIS 16
466 CANCER PAIN 15
467 COMA 15
468 CONTRAINDICATED PRODUCT ADMINISTERED 15
469 CYTOMEGALOVIRUS INFECTION 15
470 DYSURIA 15
471 ELECTROCARDIOGRAM QT PROLONGED 15
472 HAEMOLYTIC ANAEMIA 15
473 HALLUCINATION, VISUAL 15
474 HEPATITIS C 15
475 HOSPITALISATION 15
476 JOINT NOISE 15
477 MENTAL STATUS CHANGES 15
478 MOUTH SWELLING 15
479 MUSCLE TWITCHING 15
480 NIGHT SWEATS 15
481 NOSOCOMIAL INFECTION 15
482 PANIC ATTACK 15
483 PARALYSIS 15
484 PNEUMONIA BACTERIAL 15
485 POLLAKIURIA 15
486 PRODUCT AVAILABILITY ISSUE 15
487 PULMONARY HYPERTENSION 15
488 RIGHT VENTRICULAR FAILURE 15
489 SLEEP DEFICIT 15
490 SUBDURAL HAEMATOMA 15
491 THERAPY INTERRUPTED 15
492 THERAPY PARTIAL RESPONDER 15
493 TOXIC SKIN ERUPTION 15
494 ACUTE HEPATIC FAILURE 14
495 ACUTE LEFT VENTRICULAR FAILURE 14
496 AGRANULOCYTOSIS 14
497 BILIARY SEPSIS 14
498 BLOOD PRESSURE ABNORMAL 14
499 BRONCHIAL HYPERREACTIVITY 14
500 DRY MOUTH 14
501 EMBOLISM 14
502 FREQUENT BOWEL MOVEMENTS 14
503 GASTRIC HAEMORRHAGE 14
504 HYPOMAGNESAEMIA 14
505 IMPAIRED QUALITY OF LIFE 14
506 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14
507 JOINT RANGE OF MOTION DECREASED 14
508 MENINGITIS ASEPTIC 14
509 NEOPLASM MALIGNANT 14
510 NODULE 14
511 ONYCHOMYCOSIS 14
512 PARAESTHESIA ORAL 14
513 PERIPHERAL ISCHAEMIA 14
514 PHARYNGITIS 14
515 PHOTOPHOBIA 14
516 PNEUMONIA FUNGAL 14
517 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 14
518 PROCTALGIA 14
519 PRODUCT LABEL CONFUSION 14
520 PRODUCT PRESCRIBING ERROR 14
521 RASH MACULAR 14
522 UNEVALUABLE EVENT 14
523 VASCULAR DEVICE INFECTION 14
524 ACIDOSIS 13
525 ACNE 13
526 ADVERSE EVENT 13
527 BLOOD POTASSIUM DECREASED 13
528 BLOOD PRESSURE DIASTOLIC INCREASED 13
529 BLOOD THYROID STIMULATING HORMONE INCREASED 13
530 CLONUS 13
531 DIFFUSE LARGE B-CELL LYMPHOMA 13
532 DRUG WITHDRAWAL SYNDROME 13
533 DYSPNOEA EXERTIONAL 13
534 EAR INFECTION 13
535 EOSINOPHIL COUNT INCREASED 13
536 ESCHERICHIA INFECTION 13
537 FOOT DEFORMITY 13
538 HAEMOLYSIS 13
539 HAEMORRHOIDS 13
540 HYPOVENTILATION 13
541 IMPAIRED HEALING 13
542 INJECTION SITE ERYTHEMA 13
543 INTERNATIONAL NORMALISED RATIO INCREASED 13
544 IRON DEFICIENCY 13
545 NYSTAGMUS 13
546 OCULAR HYPERAEMIA 13
547 PANCREATITIS ACUTE 13
548 PAPULE 13
549 PARTIAL SEIZURES 13
550 PRODUCT ADMINISTRATION ERROR 13
551 RED CELL DISTRIBUTION WIDTH INCREASED 13
552 RESPIRATORY DEPRESSION 13
553 ROAD TRAFFIC ACCIDENT 13
554 SUBARACHNOID HAEMORRHAGE 13
555 TENOSYNOVITIS 13
556 THERAPEUTIC RESPONSE SHORTENED 13
557 TUMOUR HAEMORRHAGE 13
558 URINARY INCONTINENCE 13
559 URINE ABNORMALITY 13
560 VENOUS THROMBOSIS 13
561 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13
562 ABORTION SPONTANEOUS 12
563 ABSCESS ORAL 12
564 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12
565 AMYLASE INCREASED 12
566 AUTONOMIC NERVOUS SYSTEM IMBALANCE 12
567 BLOOD PRESSURE DIASTOLIC ABNORMAL 12
568 CHOLELITHIASIS 12
569 COLD SWEAT 12
570 CONCOMITANT DISEASE AGGRAVATED 12
571 CRYING 12
572 CYTOPENIA 12
573 DIZZINESS POSTURAL 12
574 DYSARTHRIA 12
575 EMBOLIC STROKE 12
576 FAECES DISCOLOURED 12
577 FEEDING DISORDER 12
578 FINE MOTOR SKILL DYSFUNCTION 12
579 FLUID RETENTION 12
580 GLYCOSYLATED HAEMOGLOBIN INCREASED 12
581 HAEMORRHAGIC DISORDER 12
582 HYPERBILIRUBINAEMIA 12
583 HYPORESPONSIVE TO STIMULI 12
584 INFUSION SITE SWELLING 12
585 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 12
586 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12
587 LOWER RESPIRATORY TRACT CONGESTION 12
588 MALNUTRITION 12
589 MOVEMENT DISORDER 12
590 NEPHROLITHIASIS 12
591 NERVE INJURY 12
592 ONYCHOCLASIS 12
593 PELVIC PAIN 12
594 PRODUCT QUALITY ISSUE 12
595 PROTHROMBIN TIME PROLONGED 12
596 PSEUDOMONAS INFECTION 12
597 SKIN EXFOLIATION 12
598 SPLENOMEGALY 12
599 TENDERNESS 12
600 THROAT TIGHTNESS 12
601 TRANSIENT ISCHAEMIC ATTACK 12
602 TYPE 2 DIABETES MELLITUS 12
603 URINARY TRACT DISORDER 12
604 VIRAL INFECTION 12
605 WEIGHT LOSS POOR 12
606 WRONG DRUG ADMINISTERED 12
607 ADNEXAL TORSION 11
608 ANGINA PECTORIS 11
609 ARTERIAL HAEMORRHAGE 11
610 ATRIOVENTRICULAR BLOCK COMPLETE 11
611 BLOOD SODIUM DECREASED 11
612 CATARACT 11
613 CEREBRAL ISCHAEMIA 11
614 CONJUNCTIVITIS 11
615 COORDINATION ABNORMAL 11
616 COVID-19 PNEUMONIA 11
617 DEFORMITY 11
618 DEVICE EXPULSION 11
619 DRUG LEVEL INCREASED 11
620 DYSMENORRHOEA 11
621 EXPIRED PRODUCT ADMINISTERED 11
622 EXTRAPYRAMIDAL DISORDER 11
623 EXTRAVASATION 11
624 FALLOPIAN TUBE DISORDER 11
625 FEMUR FRACTURE 11
626 FIBRIN D DIMER INCREASED 11
627 FIBROMA 11
628 FULL BLOOD COUNT ABNORMAL 11
629 HYPOKINESIA 11
630 IMMUNE THROMBOCYTOPENIC PURPURA 11
631 INFERTILITY 11
632 INTENTIONAL PRODUCT MISUSE 11
633 IRON DEFICIENCY ANAEMIA 11
634 JOINT ANKYLOSIS 11
635 LIGAMENT SPRAIN 11
636 LIMB DISCOMFORT 11
637 LIVER FUNCTION TEST INCREASED 11
638 LUNG INFECTION 11
639 LUNG INFILTRATION 11
640 NAIL INFECTION 11
641 NEURALGIA 11
642 OLIGOMENORRHOEA 11
643 ORAL PAIN 11
644 PLEURISY 11
645 PLEURITIC PAIN 11
646 POST PROCEDURAL HYPOTENSION 11
647 PREGNANCY 11
648 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11
649 PROTEINURIA 11
650 RASH PAPULAR 11
651 RHEUMATOID NODULE 11
652 SALIVARY HYPERSECRETION 11
653 TENDONITIS 11
654 THROMBOPHLEBITIS 11
655 TOOTH DISORDER 11
656 URINE KETONE BODY PRESENT 11
657 VIRAL UPPER RESPIRATORY TRACT INFECTION 11
658 ACCIDENTAL OVERDOSE 10
659 AGEUSIA 10
660 ANAPHYLACTOID REACTION 10
661 BASOPHIL COUNT INCREASED 10
662 BLOOD LOSS ANAEMIA 10
663 CLOSTRIDIUM DIFFICILE INFECTION 10
664 COAGULATION TIME PROLONGED 10
665 CYTOKINE RELEASE SYNDROME 10
666 DERMATITIS BULLOUS 10
667 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10
668 EPSTEIN-BARR VIRUS INFECTION 10
669 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 10
670 GASTRIC DISORDER 10
671 GASTRIC ULCER 10
672 GENITAL HAEMORRHAGE 10
673 HAEMORRHAGE SUBCUTANEOUS 10
674 HEAD DISCOMFORT 10
675 HEPATIC CIRRHOSIS 10
676 HYDRONEPHROSIS 10
677 HYPERCALCAEMIA 10
678 HYPOAESTHESIA ORAL 10
679 HYPOPNOEA 10
680 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10
681 INCORRECT ROUTE OF DRUG ADMINISTRATION 10
682 INTESTINAL ISCHAEMIA 10
683 INTESTINAL OBSTRUCTION 10
684 JAUNDICE NEONATAL 10
685 LOCALISED INFECTION 10
686 MENTAL IMPAIRMENT 10
687 MOUTH ULCERATION 10
688 MUSCULOSKELETAL CHEST PAIN 10
689 MYOCARDIAL ISCHAEMIA 10
690 NEONATAL RESPIRATORY DISTRESS 10
691 OXYGEN SATURATION ABNORMAL 10
692 PARANOIA 10
693 PERFORATION 10
694 PLATELET DISORDER 10
695 PRODUCT APPEARANCE CONFUSION 10
696 PRODUCT DISTRIBUTION ISSUE 10
697 PRODUCT DOSE OMISSION IN ERROR 10
698 RENAL INJURY 10
699 RESPIRATORY RATE INCREASED 10
700 SENSITIVITY TO WEATHER CHANGE 10
701 SKIN INFECTION 10
702 SLEEP DISORDER 10
703 THROMBOTIC THROMBOCYTOPENIC PURPURA 10
704 URINARY TRACT OBSTRUCTION 10
705 UROSEPSIS 10
706 VULVOVAGINAL DISCOMFORT 10
707 WOUND INFECTION 10
708 ABNORMAL UTERINE BLEEDING 9
709 ANURIA 9
710 ARTERIOSCLEROSIS 9
711 ATELECTASIS 9
712 ATRIAL THROMBOSIS 9
713 BACTERIAL TEST POSITIVE 9
714 BLINDNESS UNILATERAL 9
715 BLOOD POTASSIUM INCREASED 9
716 DEVICE ISSUE 9
717 DISABILITY ASSESSMENT SCALE SCORE INCREASED 9
718 DYSGEUSIA 9
719 EJECTION FRACTION DECREASED 9
720 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9
721 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 9
722 ELECTROENCEPHALOGRAM ABNORMAL 9
723 FEELING OF BODY TEMPERATURE CHANGE 9
724 FEMORAL NECK FRACTURE 9
725 HEPATITIS ACUTE 9
726 HYPERPROLACTINAEMIA 9
727 HYPERREFLEXIA 9
728 HYPOTHYROIDISM 9
729 ILEUS PARALYTIC 9
730 ILL-DEFINED DISORDER 9
731 INFUSION SITE DISCOMFORT 9
732 INFUSION SITE PRURITUS 9
733 INJECTION SITE REACTION 9
734 INJECTION SITE SWELLING 9
735 INSURANCE ISSUE 9
736 INTERMENSTRUAL BLEEDING 9
737 INTRACARDIAC THROMBUS 9
738 INTRAVENTRICULAR HAEMORRHAGE 9
739 JOINT INJURY 9
740 LUNG NEOPLASM MALIGNANT 9
741 MATERNAL EXPOSURE BEFORE PREGNANCY 9
742 MATERNAL EXPOSURE DURING BREAST FEEDING 9
743 MOOD ALTERED 9
744 MOTOR DYSFUNCTION 9
745 NERVOUS SYSTEM DISORDER 9
746 OESOPHAGEAL CANDIDIASIS 9
747 OESOPHAGEAL HAEMORRHAGE 9
748 PHOTOSENSITIVITY REACTION 9
749 POSTOPERATIVE WOUND INFECTION 9
750 PSORIASIS 9
751 RASH PUSTULAR 9
752 RETCHING 9
753 SKIN LACERATION 9
754 SUSPECTED OFF LABEL USE 9
755 THERAPEUTIC PRODUCT EFFECT DELAYED 9
756 THERAPY CESSATION 9
757 TONGUE OEDEMA 9
758 TOOTH FRACTURE 9
759 TRI-IODOTHYRONINE FREE DECREASED 9
760 TROPONIN INCREASED 9
761 TUBULOINTERSTITIAL NEPHRITIS 9
762 UPPER RESPIRATORY TRACT INFLAMMATION 9
763 VENTRICULAR ARRHYTHMIA 9
764 WALKING AID USER 9
765 ABDOMINAL PAIN LOWER 8
766 ABNORMAL WEIGHT GAIN 8
767 ABSCESS 8
768 ANAL ABSCESS 8
769 ANHEDONIA 8
770 APPENDICITIS 8
771 ARTERIAL THROMBOSIS 8
772 ARTHROPATHY 8
773 AZOTAEMIA 8
774 BLOOD BLISTER 8
775 BLOOD CREATINE INCREASED 8
776 CARDIAC DISORDER 8
777 CARDIOMYOPATHY 8
778 CENTRAL VENOUS CATHETERISATION 8
779 CHOLANGITIS 8
780 CHOLECYSTITIS 8
781 COLITIS ULCERATIVE 8
782 CYSTITIS 8
783 DEAFNESS 8
784 DIPLOPIA 8
785 DRUG ABUSE 8
786 DUODENAL ULCER 8
787 DYSCHROMATOPSIA 8
788 ERYTHEMA MULTIFORME 8
789 EYE DISORDER 8
790 EYELID OEDEMA 8
791 FACIAL PARALYSIS 8
792 FEAR 8
793 FIBRIN DEGRADATION PRODUCTS INCREASED 8
794 FIBROMYALGIA 8
795 FLANK PAIN 8
796 GAIT INABILITY 8
797 GASTROINTESTINAL VIRAL INFECTION 8
798 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8
799 HAEMOPHILIA 8
800 HEPATOMEGALY 8
801 HEPATOSPLENOMEGALY 8
802 HYPERACUSIS 8
803 HYPERCAPNIA 8
804 HYPOTHERMIA 8
805 HYPOTONIA 8
806 INFUSION SITE ERYTHEMA 8
807 INFUSION SITE RASH 8
808 INFUSION SITE SCAR 8
809 INFUSION SITE WARMTH 8
810 INJECTION SITE HAEMORRHAGE 8
811 INTESTINAL HAEMORRHAGE 8
812 JOINT DISLOCATION 8
813 KNEE ARTHROPLASTY 8
814 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8
815 LABILE BLOOD PRESSURE 8
816 LANGUAGE DISORDER 8
817 METRORRHAGIA 8
818 MITRAL VALVE INCOMPETENCE 8
819 NEUROLEPTIC MALIGNANT SYNDROME 8
820 NO THERAPEUTIC RESPONSE 8
821 ODYNOPHAGIA 8
822 OVARIAN VEIN THROMBOSIS 8
823 PCO2 DECREASED 8
824 PERIPHERAL COLDNESS 8
825 POOR QUALITY SLEEP 8
826 PULMONARY THROMBOSIS 8
827 PULMONARY TOXICITY 8
828 RENAL DISORDER 8
829 SKIN ULCER 8
830 SPINAL COMPRESSION FRACTURE 8
831 SPONTANEOUS HAEMORRHAGE 8
832 STAPHYLOCOCCAL BACTERAEMIA 8
833 SYSTEMIC LUPUS ERYTHEMATOSUS 8
834 SYSTOLIC DYSFUNCTION 8
835 TOOTH EXTRACTION 8
836 TRAUMATIC HAEMORRHAGE 8
837 URINE LEUKOCYTE ESTERASE POSITIVE 8
838 VENA CAVA THROMBOSIS 8
839 VERTIGO 8
840 WOUND HAEMORRHAGE 8
841 WOUND SECRETION 8
842 ACUTE CORONARY SYNDROME 7
843 ACUTE PULMONARY OEDEMA 7
844 ADVERSE DRUG REACTION 7
845 ALLERGIC REACTION TO EXCIPIENT 7
846 APHONIA 7
847 ASPIRATION 7
848 ATRIAL FLUTTER 7
849 BACTERIAL SEPSIS 7
850 BLADDER DISORDER 7
851 BLOOD FIBRINOGEN DECREASED 7
852 BLOOD PRESSURE SYSTOLIC INCREASED 7
853 BRAIN HERNIATION 7
854 CATHETER SITE HAEMORRHAGE 7
855 CHROMATURIA 7
856 COMPARTMENT SYNDROME 7
857 CONGENITAL ORAL MALFORMATION 7
858 CORONARY ARTERY DISEASE 7
859 DEPRESSION SUICIDAL 7
860 DISABILITY 7
861 DISINHIBITION 7
862 DREAMY STATE 7
863 DRUG EFFECT DECREASED 7
864 DRUG EFFECT LESS THAN EXPECTED 7
865 ELECTROCARDIOGRAM PR SHORTENED 7
866 END STAGE RENAL DISEASE 7
867 ENTEROCOCCAL INFECTION 7
868 FOOD INTOLERANCE 7
869 GASTRIC ULCER HAEMORRHAGE 7
870 GASTROINTESTINAL WALL THICKENING 7
871 GOUT 7
872 GRAFT VERSUS HOST DISEASE 7
873 HAEMOPHILIC ARTHROPATHY 7
874 HAEMORRHAGIC TRANSFORMATION STROKE 7
875 HAEMORRHOIDAL HAEMORRHAGE 7
876 HEPATIC ENCEPHALOPATHY 7
877 HEPATIC STEATOSIS 7
878 HIP ARTHROPLASTY 7
879 HYPERTRICHOSIS 7
880 INFLAMMATORY MARKER INCREASED 7
881 INJECTION SITE RASH 7
882 INTESTINAL PERFORATION 7
883 ISCHAEMIC CEREBRAL INFARCTION 7
884 LIP OEDEMA 7
885 LIVER INJURY 7
886 MASTITIS 7
887 MENSTRUATION IRREGULAR 7
888 MESENTERIC VASCULAR INSUFFICIENCY 7
889 MIOSIS 7
890 NECROSIS 7
891 NEPHROGENIC ANAEMIA 7
892 ORAL HERPES 7
893 OSTEONECROSIS 7
894 OSTEOPENIA 7
895 OSTEOPOROSIS 7
896 PARADOXICAL DRUG REACTION 7
897 PARENTERAL NUTRITION 7
898 PARESIS 7
899 PERIPHERAL ARTERY THROMBOSIS 7
900 PERONEAL NERVE PALSY 7
901 POLYNEUROPATHY 7
902 PROCALCITONIN INCREASED 7
903 PRODUCT CONTAINER ISSUE 7
904 PROTEIN TOTAL DECREASED 7
905 PULMONARY ARTERIAL HYPERTENSION 7
906 PULMONARY CONGESTION 7
907 PULMONARY INFARCTION 7
908 PUNCTURE SITE HAEMORRHAGE 7
909 PYELONEPHRITIS 7
910 QUALITY OF LIFE DECREASED 7
911 RADICULOPATHY 7
912 REBOUND EFFECT 7
913 RIB FRACTURE 7
914 SCAB 7
915 SPUTUM INCREASED 7
916 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7
917 THIRST 7
918 TONIC CLONIC MOVEMENTS 7
919 TORSADE DE POINTES 7
920 UPPER LIMB FRACTURE 7
921 VENOOCCLUSIVE DISEASE 7
922 VENTRICULAR HYPOKINESIA 7
923 VISUAL ACUITY REDUCED 7
924 VON WILLEBRAND^S FACTOR INHIBITION 7
925 WITHDRAWAL SYNDROME 7
926 ADMINISTRATION SITE PAIN 6
927 ANOSMIA 6
928 APLASIA 6
929 APNOEA 6
930 ASPERGILLUS INFECTION 6
931 BEDRIDDEN 6
932 BENIGN PROSTATIC HYPERPLASIA 6
933 BK VIRUS INFECTION 6
934 BLOOD CHLORIDE INCREASED 6
935 BLOOD CHOLESTEROL INCREASED 6
936 BLOOD FIBRINOGEN INCREASED 6
937 BLOOD URIC ACID INCREASED 6
938 BODY TEMPERATURE DECREASED 6
939 BRAIN STEM HAEMORRHAGE 6
940 CACHEXIA 6
941 CANDIDA INFECTION 6
942 CARDIOTOXICITY 6
943 CEREBELLAR INFARCTION 6
944 CEREBRAL ARTERY THROMBOSIS 6
945 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6
946 CLOSTRIDIUM DIFFICILE COLITIS 6
947 COMPLICATION ASSOCIATED WITH DEVICE 6
948 DECUBITUS ULCER 6
949 DERMATITIS 6
950 DERMATITIS ATOPIC 6
951 DIABETES INSIPIDUS 6
952 DRUG DEPENDENCE 6
953 DRUG LEVEL DECREASED 6
954 DYSTONIA 6
955 EAR PAIN 6
956 ELECTROLYTE IMBALANCE 6
957 EMOTIONAL DISORDER 6
958 ESCHERICHIA BACTERAEMIA 6
959 FACTOR VII DEFICIENCY 6
960 FLUID OVERLOAD 6
961 FULL BLOOD COUNT DECREASED 6
962 GESTATIONAL DIABETES 6
963 HAEMOPERITONEUM 6
964 HAND FRACTURE 6
965 HEPATITIS 6
966 HER2 POSITIVE BREAST CANCER 6
967 HYPOACUSIS 6
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
969 INJECTION SITE BRUISING 6
970 INJECTION SITE HAEMATOMA 6
971 INJECTION SITE PRURITUS 6
972 INTENSIVE CARE 6
973 KLEBSIELLA INFECTION 6
974 LABORATORY TEST ABNORMAL 6
975 LARYNGITIS 6
976 LUNG CANCER METASTATIC 6
977 METASTASES TO CENTRAL NERVOUS SYSTEM 6
978 METASTASES TO LIVER 6
979 MUSCULOSKELETAL DISORDER 6
980 NERVOUSNESS 6
981 NEUROGENIC SHOCK 6
982 NEUROLOGICAL SYMPTOM 6
983 OBESITY 6
984 OSTEITIS 6
985 PHARYNGEAL HAEMORRHAGE 6
986 PLASMA CELL LEUKAEMIA 6
987 POISONING 6
988 PORTAL VEIN THROMBOSIS 6
989 PROCEDURAL COMPLICATION 6
990 PRODUCT PREPARATION ISSUE 6
991 PRODUCT USE COMPLAINT 6
992 PROTHROMBIN TIME SHORTENED 6
993 PSORIATIC ARTHROPATHY 6
994 PUNCTURE SITE HAEMATOMA 6
995 RHINITIS 6
996 SENSATION OF FOREIGN BODY 6
997 SENSORY DISTURBANCE 6
998 SERUM FERRITIN INCREASED 6
999 SKIN EROSION 6